Evaluation of the Influence of Short Term Fasting Diet on Chemotherapy-induced Toxicities in Breast Cancer Patients

Last updated: September 21, 2023
Sponsor: University of Thessaly
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

fasting diet

Clinical Study ID

NCT06015087
Fasting diet
  • Ages 18-75
  • Female
  • Accepts Healthy Volunteers

Study Summary

This is a clinical trial aiming to assess the effect of fasting diet on chemotherapy - induced toxicities in breast cancer patients. The study will have an intevention group and a control group. The intervention group will follow a fasting diet of 60 hours (36h prior chemotherapy and 24h after the end of chemotherary), while the control group will follow regular (standard) diet. At the meantime of the chemotherapy cycles, the intervention group will be recommended to follow the Mediterranean diet.

The main questions this study is aiming to answer is whether short term fasting diet influences chemotherary - induced toxicities and if it is easy to be implemented.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • breast cancer patients with first diagnosis of breast cancer
  • no distinct metastasis
  • patients will receive at least 4 cycles of adjuvant or neo-adjuvant chemotherapy

Exclusion

Exclusion Criteria:

  • BMI<19kg/m2
  • unintentional weight loss of >3 or >5 kg the last 3 or 6 months respectively
  • medical history of anorexia nervosa, boulimia or any other eating disorders
  • renal failure (creatinine >2mg/dl)
  • diabetes mellitus (type I or Insulin dependent type II)
  • serious psychiatric disease
  • serious cardiovascular disease
  • mobility limitations
  • being participant in any other study

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: fasting diet
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
July 31, 2024

Study Description

This is a clinical trial aiming to assess the effect of fasting diet on chemotherapy - induced toxicities in breast cancer patients. The study will have an intevention group and a control group. The intervention group will follow a fasting diet for 60 hours (36h prior chemotherapy and 24h after the end of chemotherapy), while the control group will follow regular diet. At the meantime of the chemotherapy cycles, the intervention group will be recommended to follow the Mediterranean diet. The patients will be randomized in the two groups. A total of 50 patients is required. Biochemical data, anthropometric measures and grading of toxicity according to National Cancer Institute Common Terminology Criteria for Adverse Events, nutritional habits, adherence to the Mediterranean diet (implementation of MedDietScore) will be assessed prior, during and after the intervention, in both groups. Nutritional counseling will be performed by Registered Dietitian, and telephone interviews will be used to record adherence to fasting diet and Mediterranean diet.

The main questions this study is aiming to answer is whether short term fasting diet influences chemotherary - induced toxicities and if it is easy to be implemented.

Connect with a study center

  • Department of Nutrition-Dietetics

    Tríkala, Thessaly 42132
    Greece

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.